Fit-for-purpose global data at scale.
PLEASE NOTE: Data availability in Snowflake is determined by your organization’s or customer’s data subscriptions with IQVIA.
IQVIA is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science – leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science – to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation, and accelerate improvements in healthcare outcomes. IQVIA has the largest global healthcare data networks in the world, with over 1 million data sources providing access to 800M+ non-identified patient records and 95B+ healthcare records processed annually in over 100 countries. IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, and execution capabilities.
IQVIA customers are often challenged with centralized provisioning of their global data deliverables and aligning them into a common structure for cross-functional analytics. Enabled by the IQVIA Human Data Science Cloud, IQVIA’s Data-as-a-Service (DaaS) offering provides a centralized hosting and data management solution to source, standardize, integrate and access IQVIA data– enabling you to gain more use and value from your global data assets. Beyond just data provisioning, IQVIA data can be standardized and integrated via IQVIA’s Global Data Model (GDM). The IQVIA Global Data Model (GDM) is the most comprehensive health data standard, providing a robust data model and the necessary information to be used as a health data exchange specification. It provides a single integrated definition of data and structures, unbiased of any system or perspective. Using a common language and framework for integration, it increases data consistency and increases coherence across systems. The GDM provides a framework for data enrichment and is continuously evolving to align with industry changes.
IQVIA data products available via Data-as-a-Service on Snowflake include but are not limited to:
-OneKey: OneKey is a reference data asset that provides a complete and integrated view of the evolving environment by linking prescribers and their many locations to their affiliates with group practices, hospitals, clinics and other healthcare provider organizations, with insights into 680K organizations and 9M+ professionals. Please see the usage examples below for a sample of fields provided.
-Xponent: A suite of sub-national reporting providing granular prescription performance aligned to help manage customer operations, sales targeting, and representative incentive compensation
-DDD: For over 40 years, DDD has been providing pharmaceutical manufacturers with insight into which non-retail outlets are purchasing their and their competitors’ products and how sales change over time. DDD provides zip-code and account-level sales of prescription products sold into retail, non-retail and mail channels.
-APLD: APLD is IQVIA’s Anonymized Patient Level Data – the lowest level of granularity of transactional patient data containing longitudinal prescription (LRx) and medical claims (Dx) data.
-LAAD: LAAD is an all-inclusive master patient centric dataset, which integrates Longitudinal Prescriptions (LRx), Lifecycle (FIA) and Professional Medical (Dx) transaction claims with the option to also include Institutional Medical (Hx) and Remittance claims. LAAD not only integrates the datasets, LAAD claims are cleansed and business logic is applied. Primary and Secondary payer information and copays are integrated into LAAD as well.
-National Sales Data: Continuous country level market surveys that measure sales of registered medicines either into or out of retail pharmacies, hospitals, or other dispensing channels.
-National Prescription Data: Continuous country level market survey that measures sales of registered medicines against a prescription from retail pharmacies to consumers, based on a representative pharmacy sample. Unlike sales audits, includes information on number of prescriptions and prescribing activity by doctor speciality.
-Sub-National Sales Data: Continuous Information regarding sales of registered drugs either into or out of retail pharmacies or hospitals, and reported in detailed geographic territories, or bricks, enabling more granular understanding of volume of sales per territory.
-Sub-National Prescription Data: Continuous market survey that measures prescriptions of registered medicines dispensed from retail pharmacies, and reported in detailed geographic territories, or bricks, and in some markets with the ability to link the data back to the origin of the prescription and doctor specialty.
-Channel Dynamics: Continuous information service providing key metrics and benchmark insights into competitive sales force and marketing channel activity of the pharma industry, based on a proprietary online daily diary survey of over 30,000 HCPs across 30+ countries, capturing their exposure to life-science communication channels, the resulting data are processed and projected to show both promotional contact volume and investment by channel at company and brand level.
-LRx: Longitudinal patient-level prescription data at national and subnational level sourced from computerized dispensed prescription records at the anonymized patient level collected from retail pharmacies.
Benefits customers see are:
-Reduced delivery time and enabled quicker access to standardized data
-A single data repository for IQVIA data across client user groups
-Reduced client cost and overhead in centralizing global data assets